References
[1] S. Shamaila, N. Zafar, S. Riaz, R. Sharif, et. al., ““Gold Nanoparticles: An Efficient Antimicrobial Agent against Enteric Bacterial Human Pathogen”, Nanomaterials, Vol. 6, pp. 71, 2016.
[2] T. Hava Lofton, “Mechanisms and Biological Costs of Bacterial Resistance to Antimicrobial Peptides” Ph.D. dissertation, Abbrev. Faculty of Medicine, Uppsala Univ., City of Univ., Abbrev. State, 2016.
[3] S. Talath, AK. Gadad, “Synthesis, antibacterial and antitubercular activities of some 7- [4-(5-amino- [1,3,4] thiadiazole-2-sulfonyl)- piperazin1-yl] fluoroquinolonic derivatives“, Eur. J. Med Chem., Vol.41, pp.918-24, 2006
[4] O. Pintilie, L. Profire, V. Sunel, et al., “Synthesis & Antimicrobial Activity of Some New 1,3,4-Thiadiazole & 1,2,4- Triazole Compounds Having a D, L-Methionine Moiety“, Molecules, Vol.12, pp.103-13, 2007.
[5] A. Foroumadi, A. Rineh, S. Emami, F. Siavoshi, S. Massarrat, F. Safari et al., “Synthesis & anti-Helicobacter pylori activity of 5- (nitroaryl)-1,3,4- thiadiazoles with certain sulfur containing alkyl side chain Paper title“, Bio-org Med. Chem. Lett, Vol.18, pp. 3315-15, 2008.
[6] A. Foroumadi, S. Emami, A. Hassanzadeh, M. Rajaee, K. Sokhanvar, MH. Moshafi et. al., “Synthesis & antibacterial activity of N- (5-benzylthio-1, 3, 4- thiadiazol-2-yl) and N-(5- benzylsulfonyl-1, 3, 4-thiadiazol-2- yl) piperazinyl quinolone derivatives,” Bio-org Med. Chem. Lett, Vol.15, No 5, pp.4488-92, 2005.
[7] P. Mishra, H. Rajak, “Performance Analysis of Reactive and Proactive Routing Protocols for Mobile Ad-hoc N/W,” World Academics Journal of Engineering Sciences, Vol.1, No 5, pp.1-4, 2013.
[8] U. S. Goksen, N. G. Kelekci, O. Goktas, Y. Koysal, E. Kilic, S. Isik, G. Aktay, M. Ozalp, “1-Acylthiosemicarbazide, 1,2,4- triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl -2-benzoxazolines : Synthesis, analgesic anti-inflammatory and antimicrobial activities,” Bioorganic & Medicinal Chemistry, Vol.15, No 5, pp.5738-5751, 2007.
[9] E. Palaska, G. Sahin, P. Kelicen, N.T. Durlu, G. Altinok “Synthesis and anti-inflammatory activity of 1-acylthiosemicarbazides, 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazole-3-thiones,” Farmaco, Vol. 57, No 2, pp.101-107, 2002.
[10] A. E. Gazzar, M I Hegab “Bioorganic and Medicinal Chemistry Letters,” World Academics Journal of Engineering Sciences, Vol.18, No 5, pp.4538-4543, 2008.
[11] A. Aziem, “J. Heterocycl. Chem.,” International Journal of Scientific Research in Biological Sciences, Vol. 52, Issue 1, pp.251, 2015. Anti-malarial [Li, Y., Yang, Z., Zhang, H., Cao, B., Wang, F., Zhang, Y., Shi, Y., Yang, J., and Wu, B., Bioorg. Med. Chem., vol. 11, no. 20, p. 4363, 2003.
[12] L. Shi, HM Ge, SH Tan, HQ Li, YC Song, HL Zhu, RX Tan, “Synthesis & antimicrobial activities of Schiff bases derived from 5-chloro-salicylaldehyde,” European Journal of Medicinal Chemistry, Vol.42, No 4,pp.558-564, 2007.
[13] S. Hussain, J. Sharma, M. Amir, “Synthesis and antimicrobial activities of 1, 2, 4-triazole and 1, 3, 4-thiadiazole derivatives of 5-amino-2-hydroxybenzoic acid,” E-Journal of Chemistry, Vol.5, No 4, pp.963-968, 2008.
[14] P. Pattanayak, R. Sharma, P. K.Sahoo, “Synthesis and evaluation of 2-amino-5-sulfanyl-1, 3, 4-thiadiazole as antidepressant, anxiolytic, and anticonvulsant agents,” World Academics Journal of Engineering Sciences, Vol.18, No 1, pp.551-561, 2009.
[15] D.M. Bailey, et.al. “Redox regulation of neurovascular function by acetazolamide: complementary insight into mechanisms underlying high-altitude acclimatiation,” The Journal of Physiology, Vol.15, No 5, pp.3637, 2012.
[16] P.A. Datar, T.A. Deokule, “Design and Synthesis of Thiadiazole Derivatives as Antidiabetic Agents,” Med. Chem, Vol.4, No. 4, pp.390-399, 2014.
[17] S. Ren, R. Wang, K. Komatsu, P. Bonaz-Krause, Y. Zyrianov, C.E. McKenna, C. Csipke, Z.A. Tokes, & E.J. Lien, “Synthesis, biological evaluation, and quantitative structure? activity relationship analysis of new Schiff bases of hydroxysemicarbazide as potential antitumor agents,” Journal of medicinal chemistry, Vol.45, No 2, pp.410-419, 2002.
[18] M. J. Hearn, M.H. Cynamon, “Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base,” Journal of Antimicrobial Chemotherapy, Vol.53, No 5, pp.185-191, 2004.
[19] M.S. Karthikeyan, D.J. Prasad, B. Poojary, B.K. Subrahmanya, B.S. Holla, & N.S. Kumari, “Synthesis and biological activity of Schiff and Mannich bases bearing 2,4-dichloro-5-fluorophenyl moiety,” Bioorganic & Medicinal Chemistry, Vol.14, No 22, pp.7482-7489, 2006.
[20] R. K. Saksena, S. Puri, Indian Journal of Heterocyclic Chemistry, Vol.13, No 5, pp.127-130, 2003.
[21] M. Bulbul, N. Sarcoglu, et.al, “Bile acid derivatives of 5-amino-1, 3, 4-thiadiazole-2-sulfonamide as new carbonic anhydrase inhibitors: synthesis and investigation of inhibition effects,” Bioorganic & Med. Chemistry, Vol.10, No 8, pp.2561-2567, 2002.
[22] L.D. S. Yadav, S. Saigal, “A facile ring transformation of 5-oxazolone derivatives to new 1, 3, 4-oxa (thia)diazolo[3,2-a]pyrimidin-5-ones,” Indian Journal of. Chemistry, Vol.34B, No 5, pp.500-503, 1995.
[23] S. Rajesh, P. Ganesh, S. Jitendra, & C. Subhash, “Synthesis and biological evaluation of 2-amino-5-sulfanyl-1, 3, 4-thiadiazole derivatives as antidepressant, anxiolytics and anticonvulsant agents,” Medicinal Chemistry Research, Vol.20, No, pp.245-253, 2011.
[24] Z. Cimerman, S. Miljanic & N. Galic, “Schiff Bases Derived from Aminopyridines as Spectrofluorimetric Analytical Reagents,” Croatica Chemica Acta, Vol.73, No 1, pp.81-95, 2000.
[25] S. Malik, B. Nema, “Antimicrobial activities of Schiff Bases: A review,” International Journal of Theoretical & Applied Sciences, Special Issue-NCRTAST Vol.8, No 1, pp.28-30, 2016.
[26] J. Sunny, J. Anil, G. Avneet & Hemraj, “Synthesis, Biological Activities and Chemistry of Thiadiazole Derivatives and Schiff Bases,” Asian Journal of Pharmaceutical and Clinical Research, Vol.5, No 3, pp.199-208, 2012.
[27] J. Mohan, G. Anjaneyulu, R, Kiran, “Synthesis of 2-alkyl-6- aryl-imidazo (2, 1- b)-1, 3, 4-thiadiazoles & their 5-bromo derivatives for antimicrobial activity,” Journal of the Indian Chemical Society, Vol.66, No 1-6, pp.118--122, 1989.
[28] A. A. Fawzia, N S. Habib, S. Nargues, Mel Taibbi, S. Dine, A. S. E. Dine, “Synthesis of imidazo(2, 1-b)-1, 3, 4-thiadiazole derivatives as antibacterial agents against Escheria coli & Candida albicans,” Chem. Abst, Vol., No , pp., 1991.
[29] B. S. Holla, K.N. Poorjary, B.S. Rao, M.K. Shivananda, “New bis-aminomercaptotriazoles & bis-triazolothiadiazoles as possible anticancer agents,” European Journal of Medicinal Chemistry, Vol.37, No 6, pp.511-517, 2002.
[30] E. Yousif, A. Majeed, K. Al-Sammarraeb, N. Salih, J. Salimon, B. Abdullah, “Metal complexes of Schiff base: Preparation, characterization & antibacterial activity,” Arabian Journal of Chemistry, Vol.10, No -, pp.1-6, 2017.
[31] M. N. Mousa, “Synthesis, Characterization & evaluation of antibacterial activity of 1,3,4- Thiadiazole derivatives containing Schiff bases,” International Journal of Pharmaceutical, Chemical and Biological Sciences, Vol.7, No.1, pp.71-76, 2017.
[32] R.J. Cruickshank; R. R. Duguid, “Swain Medical,” First Edition, Med. Microbiology, Churchill Livingstone, pp.-, 1998.
[33] M. N. Mousa, “Synthesis, Characterization, & Biological Evaluation of Antibacterial Activity of 4H 1,2,4-triazole-5-(4- Bromophenoxymethyl)- 3-(4-substituted Benzyl) sulfide,” Biological Forum– An International Journal, Vol.1, No 5, pp.1-4, 2013.
[34] R.L. Jadhav, H.U. Joshi, S.B. Ubale, “Synthesis, characterization and biological activities of some novel Schiff bases derived from 3-acetyl-4-hydroxy-2H-chromen-2-one and 5-(4-substituted phenyl)-1,3,4-thiadiazol-2-amine,” Journal of Interdisciplinary Cycle Research, Vol. XIII, No X, pp.414-424, 2021.
[35] R.L Jadhav., H.U. Joshi, S.B. Ubale, “Synthesis, characterization and biological activities of some novel Schiff bases derived from 3-acetyl-4-hydroxy-2H-chromen-2-one and 2- amino 5-(4-halo substituted phenyl)-1, 3, 4-thiadiazole,” The International journal of analytical and experimental modal analysis, Vol. XIII, No XI, pp.452-464, 2021.
[36] V. Mutalik, M. A. Phanibandb, “Synthesis, characterization, fluorescent and antimicrobial properties of new Lanthanide(III) complexes derived from coumarin Schiff base,” Journal of Chemical and Pharmaceutical Research, Vol.3, No 2, pp.313-330, 2013.